Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Effects of Liquid Zinc Supplementation and Dispersible Zinc Tablets on Plasma Zinc Concentration

This study has been completed.
Université Polytechnique de Bobo-Dioulasso
Helen Keller International
Nutriset S.A.S.
Information provided by (Responsible Party):
University of California, Davis Identifier:
First received: July 21, 2009
Last updated: February 22, 2017
Last verified: February 2010
The study aims to compare the effects of two different formulations of zinc supplements on plasma zinc concentrations among young Burkinabe children.

Condition Intervention
Zinc Deficiency
Dietary Supplement: Liquid zinc syrup
Dietary Supplement: Zinc tablet
Dietary Supplement: Liquid placebo supplement

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Participant, Care Provider, Investigator, Outcomes Assessor
Primary Purpose: Prevention
Official Title: The Effect of Zinc Supplementation, Provided as Either a Liquid Zinc Solution or Dispersible Tablets, on Plasma Zinc Concentration Among Young Burkinabe Children

Resource links provided by NLM:

Further study details as provided by University of California, Davis:

Primary Outcome Measures:
  • Plasma zinc concentration [ Time Frame: 3 weeks ]

Enrollment: 462
Study Start Date: August 2009
Study Completion Date: February 2010
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Zinc syrup
Liquid Zinc Syrup (ZnSO4) solution provided daily
Dietary Supplement: Liquid zinc syrup
Liquid zinc syrup containing 5 mg zinc as zinc sulfate
Other Name: Phytofla, Banfora, Burkina Faso
Experimental: Zinc tablet
Dispersible zinc tablets provided daily
Dietary Supplement: Zinc tablet
Dispersible zinc tablet containing 5 mg zinc
Other Name: Nutriset S.A.S., France
Placebo Comparator: Placebo
Liquid placebo supplement provided daily
Dietary Supplement: Liquid placebo supplement
Liquid placebo supplement containing 0 mg zinc
Other Name: Phytofla, Banfora, Burkina Faso

Detailed Description:
1) To investigate the effects of short-term zinc supplementation, provided either as a dispersible tablet containing zinc sulfate ("ZinCfant," Nutriset Ltd; Malaunay, France) or as a liquid ZnSO4 solution, on changes in serum zinc concentration, compared with a placebo in young Burkinabe children; and 2) to assess the relationship between change in serum zinc concentration and the presence of altered intestinal permeability within each treatment group.

Ages Eligible for Study:   6 Months to 23 Months   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • currently breast feeding
  • informed consent of a parent or guardian.

Exclusion Criteria:

  • symptomatic acute or chronic febrile infections
  • diarrhea within the past week
  • consuming vitamin or mineral supplements or zinc-fortified infant formulas
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00944853

Burkina Faso
Toussiana Health District
Toussiana, Burkina Faso
Sponsors and Collaborators
University of California, Davis
Université Polytechnique de Bobo-Dioulasso
Helen Keller International
Nutriset S.A.S.
Principal Investigator: Kenneth H Brown, MD University of California, Davis
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: University of California, Davis Identifier: NCT00944853     History of Changes
Other Study ID Numbers: 200917272
Study First Received: July 21, 2009
Last Updated: February 22, 2017

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University of California, Davis:
zinc supplement
zinc deficiency
plasma zinc concentration

Additional relevant MeSH terms:
Trace Elements
Growth Substances
Physiological Effects of Drugs processed this record on May 25, 2017